
IBEC is working on applying a new, very significant strategy in precision medicine: theragnosis. Theragnosis is a new paradigm in medical science that combines diagnosis and therapy in favor of personalized medicine.
Centres de Recerca de Catalunya (CERCA)
Bioengineering; nanotechnology; biomaterials; tissue engineering; regenerative medicine; bioprinting; cell therapy; biomedical imaging; biosensors; nanomedicine; molecular engineering; stem cells; biophysics; synthetic biology; drug delivery systems
Want more information about TECNIO Technology Developers?
Technological capabilities
The model conceived by IBEC is inspired by a new, creative and innovative ecosystem, based on the interaction between expert researchers in different technologies (nano-bio-info-cogno) with one aim: to generate new biotechnological knowledge and engineering solutions in healthcare and pharmaceutical technology.
To achieve its objectives, IBEC employs the following distinctive technologies:
- 3D bioprinting.
- Microfluidics, lab-on-a-chip and organ-on-a-chip.
- Biosensors.
- Advanced biomaterials.
- Big data and/or biometric analysis, data mining, extraction algorithms.
- Antibiotherapy.
- Drug delivery systems.
- Nanotechnological tools and systems, nanorobots and nanobiorobots.
- Cell therapies and regenerative medicine.
- Synthetic models of biological tissues for drug screening and personalized medicine (cardiac, muscular, pancreatic, pulmonary and kidney tissue).
Technological fields

Biotechnology, Personalized medicine

POCT, Medical devices
Relevant equipment
The IBEC BioImaging Facility provides imaging tools for the in vivo, ex vivo and in vitro study of experimental models, obtaining information at the molecular, cellular or tissue level, from a physiological, anatomical or combined scope.
IBEC-Theragnosis location
